Compositions and methods of Rit1 inhibition
US10525040B2 · kind B2 · utility
0Cited by
0References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 29, 2016 |
| Grant date | Jan 7, 2020 |
| Priority date | — |
| Expiry date | Jun 29, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Various compounds, compositions, and methods for inhibition of Rit1 are presented. In especially preferred aspects, contemplated compounds and compositions are suitable for treatment of cancers and other diseases associated with Rit1 signaling.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.